Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06479356Phase 2Recruiting
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
Large B-cell LymphomaNon-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2024-08-15
NCT06149169Phase 2Unknown
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
Diffuse Large B Cell LymphomaLymphoma, Non-Hodgkin
PrincipalinvestigatorStart date: 2023-08-17
Relmacabtagene Autoleucel in Patients With LBCL
Large B-cell Lymphoma
PrincipalinvestigatorStart date: 2022-12-28

Research Network

Collaboration Network

25 collaborators·62 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Tianjin Cancer Hospital Airport Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Weili Zhao, PhD

Ruijin Hospital

Related
5 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLarge B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Huiqiang Huang, PhD

Sun Yat-sen University

Related
2 trials

Shared therapeutic areas:

Large B-cell LymphomaLymphoma, Non-Hodgkin

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Hongmei Jing

Peking University Third Hospital

Related
4 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLarge B-cell Lymphoma

Worked with same sponsors:

Shanghai Ming Ju Biotechnology Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLarge B-cell Lymphoma
Similarity Score20%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score20%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score20%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score20%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score20%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin
Similarity Score20%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, Large B-Cell, Diffuse
Similarity Score20%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06479356Phase 2PrincipalInvestigator

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

Large B-cell LymphomaNon-Hodgkin Lymphoma
Recruiting
NCT06149169Phase 2PrincipalInvestigator

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Diffuse Large B Cell LymphomaLymphoma, Non-Hodgkin
Unknown
NCT06142175PrincipalInvestigator

Relmacabtagene Autoleucel in Patients With LBCL

Large B-cell Lymphoma
Unknown

All 3 trials loaded